Post-earnings recap
Reported
Tue, Aug 7, 2012
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a strong EPS performance, exceeding expectations significantly, which contributed to a 1.51% increase in stock price. The lack of revenue data leaves some uncertainty, but the positive EPS surprise suggests effective cost management. Investors may view this as a sign of resilience in the company's operations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.69 | N/A | +42.26% |
| Revenue | N/A | N/A | N/A |
Management was pleased with the EPS results, indicating a strong performance in cost management. However, they did not offer specific revenue insights.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to enhance operational efficiency.